Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESOBLAST LTD Director's Dealing 2025

Jan 20, 2025

31658_rns_2025-01-20_c2281492-5d4c-4122-995f-4f8deb84ca20.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Mesoblast Limited
ABN
68 109 431 870

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Eric Rose
Date of last notice 16 January 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Interest in ordinary shares held in the form
of American Depositary Shares (“ADSs”)
held by custodian JP Morgan Nominees
Australia Pty Limited.
Interest in the ADSs held by Eric Rose
and Ellise Rose
Date of change 16 January 2025
No. of securities held prior to change 5,451,434 ordinary shares (including
41,162 ADS)
6,596,953 options
Class American Depositary Shares. Each ADS
represents 10 ordinary shares.
Number acquired
30,310 ADS
Number disposed Not applicable
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
US$506,214.54 (US$16.70 per ADS)
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change 5,754,534 ordinary shares (including
71,472 ADS)
6,596,953 options
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
On-market share purchase on the Nasdaq

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Not applicable
Nature of interest Not applicable
Name of registered holder
(if issued securities)
Not applicable
Date of change Not applicable
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
Not applicable
Interest acquired Not applicable
Interest disposed Not applicable
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Not applicable
Interest after change Not applicable

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above
traded during a+closed period where prior written clearance
was required?
No
If so, was prior written clearance provided to allow the trade to
proceed during this period?
Not applicable
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

If prior written clearance was provided, on what date was this Not applicable provided?

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3